ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $341.17 million. The enterprise value is $596.36 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 99.18 million shares outstanding. The number of shares has increased by 25.78% in one year.
| Current Share Class | 99.18M |
| Shares Outstanding | 99.18M |
| Shares Change (YoY) | +25.78% |
| Shares Change (QoQ) | +1.71% |
| Owned by Insiders (%) | 5.18% |
| Owned by Institutions (%) | 28.09% |
| Float | 79.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.69 |
| Forward PS | 5.63 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.46
| Current Ratio | 4.46 |
| Quick Ratio | 3.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -27.02% |
| Return on Invested Capital (ROIC) | -34.74% |
| Return on Capital Employed (ROCE) | -58.44% |
| Revenue Per Employee | $286,102 |
| Profits Per Employee | -$565,442 |
| Employee Count | 265 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 6.89 |
Taxes
In the past 12 months, ADCT has paid $168,000 in taxes.
| Income Tax | 168,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.71% in the last 52 weeks. The beta is 1.96, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | -1.71% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 2.20 |
| Relative Strength Index (RSI) | 76.01 |
| Average Volume (20 Days) | 894,381 |
Short Selling Information
The latest short interest is 4.33 million, so 4.36% of the outstanding shares have been sold short.
| Short Interest | 4.33M |
| Short Previous Month | 4.53M |
| Short % of Shares Out | 4.36% |
| Short % of Float | 5.47% |
| Short Ratio (days to cover) | 11.93 |
Income Statement
In the last 12 months, ADCT had revenue of $75.82 million and -$149.84 million in losses. Loss per share was -$1.45.
| Revenue | 75.82M |
| Gross Profit | -39.32M |
| Operating Income | -125.51M |
| Pretax Income | -170.29M |
| Net Income | -149.84M |
| EBITDA | -124.16M |
| EBIT | -125.51M |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $194.70 million in cash and $449.89 million in debt, giving a net cash position of -$255.19 million or -$2.57 per share.
| Cash & Cash Equivalents | 194.70M |
| Total Debt | 449.89M |
| Net Cash | -255.19M |
| Net Cash Per Share | -$2.57 |
| Equity (Book Value) | -238.22M |
| Book Value Per Share | -2.40 |
| Working Capital | 200.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$136.07 million and capital expenditures -$600,000, giving a free cash flow of -$136.67 million.
| Operating Cash Flow | -136.07M |
| Capital Expenditures | -600,000 |
| Free Cash Flow | -136.67M |
| FCF Per Share | -$1.38 |
Full Cash Flow StatementMargins
Gross margin is -51.86%, with operating and profit margins of -165.54% and -197.64%.
| Gross Margin | -51.86% |
| Operating Margin | -165.54% |
| Pretax Margin | -197.41% |
| Profit Margin | -197.64% |
| EBITDA Margin | -163.76% |
| EBIT Margin | -165.54% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.78% |
| Shareholder Yield | -25.78% |
| Earnings Yield | -43.92% |
| FCF Yield | -40.06% |
Analyst Forecast
The average price target for ADCT is $7.75, which is 125.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.75 |
| Price Target Difference | 125.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 35.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -7.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.91 |
| Piotroski F-Score | 3 |